Product description

Vildagliptin is an active substance for the treatment of type 2 diabetes. Its effect is caused by lowering the blood sugar level. Vildagliptin is often used in combination with Metformin and is administered orally in the form of tablets.

Comprehensive documentation for drug registration of Vildagliptin can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
274901-16-5 ASMF IH


Vildagliptin (Antidiabetic)

Country availability

Available worldwide

Hans-Günter Kainz

Contact person

Hans-Günter Kainz

General Manager

email   phone